Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal peptide, CUB domain and EGF-like domain-containing protein 3 (SCUBE3) is a secreted cell-surface glycoprotein that belongs to the SCUBE family of proteins, which are characterized by an N-terminal signal peptide, multiple EGF-like repeats, and a C-terminal CUB domain (UniProt Q8IX30). It functions primarily as a co-receptor or signaling modulator, particularly within the Bone Morphogenetic Protein (BMP) and Transforming Growth Factor-beta (TGF-beta) pathways, influencing processes such as bone development and angiogenesis (NCBI Gene ID: 222663). Recent research has highlighted its role as a potent signaling molecule produced by dermal papilla cells that can trigger hair follicle stem cell activation and hair growth (Science, 2022). In oncology, SCUBE3 is often upregulated in cancers like non-small cell lung cancer and breast cancer, where it promotes epithelial-mesenchymal transition (EMT) and metastasis by enhancing TGF-beta signaling (Nature Communications, 2014). While no FDA-approved drugs currently target SCUBE3, it is being explored as a therapeutic candidate for treating androgenetic alopecia and as a potential target for anti-metastatic cancer therapies.
SCUBE3 acts as a co-receptor that enhances BMP and TGF-beta signaling by facilitating ligand-receptor interactions; in hair follicles, it acts as a paracrine factor produced by dermal papilla cells to stimulate hair growth (Science, 2022).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal peptide, CUB domain and EGF-like domain-containing protein 3 (SCUBE3).